Daptomycin-Vancomycin–Resistant Native Valve Endocarditis

Daptomycin-Vancomycin–Resistant Native Valve Endocarditis

Multidrug-resistant enterococcal nosocomial invasive infections are a rising concern faced by the medical community. Not many options are available to treat these highly virulent organisms. Risk factors for developing these highly resistant organisms include prolonged hospital stay, previous antibio...

Full description

Bibliographic Details
Main Authors: Khandakar Hussain MD, Saad Ullah MD, Hassan Tahir MD, Waseem Zaid Alkilani MD, Muhammad Naeem MD, Nagadarshini Ramagiri Vinod MD, Samuel Massoud MD
Format: Article
Language:English
Published: SAGE Publishing 2016-09-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/2324709616665408
Description
Summary:Multidrug-resistant enterococcal nosocomial invasive infections are a rising concern faced by the medical community. Not many options are available to treat these highly virulent organisms. Risk factors for developing these highly resistant organisms include prolonged hospital stay, previous antibiotic use, and immunosuppression. In this article, we report a case of daptomycin-resistant enterococcal native infective endocarditis treated with off-label use of quinupristin-dalfopristin.
ISSN:2324-7096

Similar Items